Results 51 to 60 of about 114 (82)

Systematic literature review and meta-analysis of cardiovascular risk factor management in selected Asian countries. [PDF]

J Comp Eff Res, 2023
Yeh EJ, Grigolon RB, Rodrigues SR, A Bueno AP.   +3 more
europepmc   +1 more source

Child Sexual Abuse in Nigeria: A Systematic Review. [PDF]

Trauma Violence Abuse
Ifayomi M, Ali P, Ellis K.
europepmc   +1 more source

Buying Attitude of Yam Consumers in Southeastern, Nigeria [PDF]

Tropicultura, 2011
Nwachukwu, IN., Oteh, OU., Ugoh, CC., Ochomma, C.   +3 more
doaj  

Sex and gender differences in presentation, treatment and outcomes in acute coronary syndrome, a 10 year study from a multi-ethnic Asian population: The Malaysian National Cardiovascular Disease Database-Acute Coronary Syndrome (NCVD-ACS) registry. [PDF]

PLoS One, 2021
Lee CY, Liu KT, Lu HT, Mohd Ali R, Fong AYY, Wan Ahmad WA.   +5 more
europepmc   +1 more source

Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial. [PDF]

Eur Heart J, 2023
Schwartz GG, Szarek M, Bhatt DL, Bittner VA, Bujas-Bobanovic M, Diaz R, Fazio S, Fras Z, Goodman SG, Harrington RA, Jukema JW, Manvelian G, Pordy R, Ray KK, Scemama M, White HD, Steg PG, ODYSSEY OUTCOMES Investigators.   +17 more
europepmc   +1 more source

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. [PDF]

Circulation, 2022
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG, ODYSSEY OUTCOMES Investigators.   +19 more
europepmc   +1 more source

1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry. [PDF]

Int J Cardiol Heart Vasc, 2020
Chandrasekhar J, Baber U, Sartori S, Aquino MB, Hájek P, Atzev B, Hudec M, Kiam Ong T, Mates M, Borisov B, Warda HM, den Heijer P, Wojcik J, Iniguez A, Coufal Z, Khashaba A, Munawar M, Gerber RT, Yan BP, Tejedor P, Kala P, Bang Liew H, Lee M, Kalkman DN, Dangas GD, de Winter RJ, Colombo A, Mehran R, MASCOT investigators.   +28 more
europepmc   +1 more source

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment. [PDF]

Diabetes Care, 2021
Schwartz GG, Szarek M, Bittner VA, Bhatt DL, Diaz R, Goodman SG, Jukema JW, Loy M, Manvelian G, Pordy R, White HD, Steg PG, ODYSSEY OUTCOMES Committees and Investigators.   +12 more
europepmc   +1 more source